Page 6 - 2020年21期

YUAN Yunlong，QIAN Chunxia，ZHU Jinwei，XU Xiaowen，ZHU Yasong，LIU Jisong，SHEN Yi，LU Jian（2651）
Reappraisal of Systematic Reviews of Glucagon-like Peptide-1 Receptor Agonist in the Treatment of Type 2
Diabetes Mellitus Based on GRADE System ……………………………………………………………………
……………………………………… LIAN Guan，XIE Zhuolin，LI Meixuan，LI Yongkun，ZHANG Dinghua（2656）
Bibliometric Analysis of Research Status and Hotspot Frontier of Polypharmacy in the Elderly …………………
…………………………………………………………… QU Jiling，SHEN Yijing，ZHOU Ting，LIU Yongbing（2665）
Optimization of Anti-infective Program after Surgery for a Case of Infant Patient with Intussusception and
Enterobrosis by Clinical Pharmacists ………………………………………………………………………………
………………………………………… SU Changhai，LIU Junbao，XIE Peitao，HAO Duo，ZHANG Xiaojuan（2672）

CHINA PHARMACY （Semimonthly） Postal Address
Founded in January 1990 129 Daping Main Street，Yuzhong District，Chongqing
Vol.31，No.21，Nov. 2020 400042，China
Total No.687 Published on Nov. 15，2020 Phone
Responsible Institution 86-23-63830521；86-23-63830907
National Health Commission，P.R. China E-mail
Sponsored by info@china-pharmacy.com
Chinese Hospital Association Website
Chongqing University Cancer Hospital http：//www.china-pharmacy.com
Edited by Online Submission
China Pharmacy Editorial and Publishing Center http：//2018.china-pharmacy.com
Director of Editorial Commission Printed by
LI Linkang Chongqing Changhong Printing Co.，Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China：Chongqing Post Offices（Code No.78-33）
Honorary Editor-in-Chief Overseas：China International Book Trading Corporation
MA Jin （Code No.4703SM）
Editor-in-Chief Subscription Rates
HU Xin US $ 8.00 per issue；US $ 192.00 per annum
Vice Editor-in-Chief CSSN ISSN 1001-0408
LENG Huaiming CN 50-1055/R
Chief Editor CODEN
XIA Peiyuan ZYHAA4
Published by Perennial Legal Counsel
China Pharmacy Editorial Department Chongqing Huali Wantao Law Firm